US20040062724A1 - Erodible film for treating the surfaces of teeth - Google Patents

Erodible film for treating the surfaces of teeth Download PDF

Info

Publication number
US20040062724A1
US20040062724A1 US10/444,512 US44451203A US2004062724A1 US 20040062724 A1 US20040062724 A1 US 20040062724A1 US 44451203 A US44451203 A US 44451203A US 2004062724 A1 US2004062724 A1 US 2004062724A1
Authority
US
United States
Prior art keywords
strip
layer
erodible
polymer
water soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/444,512
Inventor
Daniel Moro
Ernest Callahan
David Nowotnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uluru Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/444,512 priority Critical patent/US20040062724A1/en
Assigned to ACCESS PHARMACEUTICALS, INC. reassignment ACCESS PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CALLAHAN, ERNEST HOWARD JR., MORO, DANIEL G., NOWOTNIK, DAVID P.
Publication of US20040062724A1 publication Critical patent/US20040062724A1/en
Priority to US11/192,524 priority patent/US20060073174A1/en
Assigned to ULURU INC. reassignment ULURU INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACCESS PHARMACEUTICALS, INC.
Assigned to ULURU INC. reassignment ULURU INC. CONVEYANCE OF ALL RIGHT, TITLE AND INTEREST TO THE CORRESPONDING FOREIGN PATENTS AND PENDING APPLICATIONS TO THE RIGHTS PREVIOUSLY RECORDED ON REEL: 017706 AND FRAME: 0576 Assignors: ACCESS PHARMACEUTICALS, INC.
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Definitions

  • This invention relates to the cosmetic or therapeutic treatment of teeth, and more specifically to an adherent, erodible film that provides an active ingredient agent to teeth surfaces for a prolonged and controlled period of time.
  • a tooth is composed of a protective, hard enamel outer layer and an inner dentin layer.
  • the enamel layer is typically opaque white or slightly off-white in color.
  • This layer is composed of hydroxyapatite mineral crystals and is somewhat porous, allowing staining agents and discoloring substances to permeate the enamel and discolor teeth.
  • staining agents and discoloring substances In particular, certain foods, tobacco products and liquids such as tea and coffee tend to stain teeth. These substances accumulate on the surface and form a film on the teeth, and will then permeate into the enamel layer. This problem occurs over many years, imparting a noticeable discoloration of the enamel layer.
  • 6,419,906 B1 describes a flexible film which when applied to stained teeth is hydrated by saliva and is effective in such form to whiten teeth.
  • the film comprises an anhydrous water hydratable ethylene oxide polymer matrix containing a solid peroxide whitening agent whereby, upon placing and positioning on stained teeth, the peroxide is solubilized and activated by the saliva present in the oral cavity.
  • composition of the bi-layered and multi-layered devices consists of an enamel adherent, water soluble, polymeric layer containing a tooth whitening agent or other active compound and a coated, erodible backing layer that controls the desired residence time. Since the devices of the current invention can provide a longer contact time with a stained tooth surface before eroding, it is expected that lower and safer amounts of whitening agents can be used to accomplish similar or superior results than attained by other commercial products.
  • An important aspect of the present invention is an erodible multilayered strip comprising at least two layers, a first layer comprises a water soluble polymer or combination of polymers that adheres to moist enamel surfaces. A second layer is water erodible and controls the residence time that the strip remains adhere to the enamel surface.
  • This erodible strip is preferably shaped to conform to an individual tooth or a row of teeth.
  • An important embodiment of the present invention involves erodible adhesive a mucoadhesive, erodible multi-layered device comprising a first, water-soluble adhesive layer to be placed in contact with a mucosal surface and a second, water-erodible non-adhesive backing layer that controls residence time of the device.
  • the first layer preferably comprises a tooth-whitening agent, at least one water-soluble film-forming polymer in combination with at least one mucoadhesive polymer; and said second, water-erodible non-adhesive backing layer comprises a precast film containing at least one of hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl alcohol, polyethylene glycol, polyethylene oxide, and ethylene oxide-propylene oxide co-polymer, said backing layer being coated with at least one hydrophobic polymer, alone or in combination with at least one hydrophilic polymer, such that the backing layer is bioerodible.
  • An important aspect of the present invention is a mucoadhesive, erodible multi-layered device comprising a first, water-soluble adhesive layer to be placed in contact with a mucosal surface and a second, water-erodible non-adhesive backing layer that controls residence time of the device.
  • the first layer comprises a tooth-whitening agent (most preferably carbamide peroxide), at least one water-soluble film-forming polymer in combination with at least one mucoadhesive polymer.
  • Said second, water-erodible non-adhesive backing layer comprises a precast film containing at least one of hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl alcohol, polyethylene glycol, polyethylene oxide, and ethylene oxide-propylene oxide co-polymer.
  • This backing layer is coated with at least one hydrophobic polymer, alone or in combination with at least one hydrophilic polymer, such that the backing layer is bioerodible.
  • the second water-erodible non-adhesive backing layer acts as a casting and support surface on which the adhesive layer is prepared.
  • a premade film of hydroxypropyl methyl cellulose in combination with a coating consisting of at least one hydrophobic polymer selected from the family of quaternary ammonium acrylate/methacrylate co-polymers, (Eudragit RS) ethyl cellulose and methyl cellulose, alone or in combination with at least one hydrophilic polymer, selected from the group consisting of polyvinyl pyrrolidone, hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, and polyvinyl alcohol.
  • hydrophobic polymer selected from the family of quaternary ammonium acrylate/methacrylate co-polymers, (Eudragit RS) ethyl cellulose and methyl cellulose
  • hydrophilic polymer selected from the group consisting of polyvinyl pyrrolidone, hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, and polyvinyl alcohol
  • a unique, erodible, layered device that adheres to tooth enamel surfaces.
  • the device is most applicable for the cosmetic treatment of stained teeth, by delivering a whitening agent or combination of agents thereof for a controlled period of time.
  • the device can also be used for the delivery of fluoride ions and phosphates for the preventative treatment of caries and tartar accumulation, respectively.
  • the device initially adheres to a moist tooth surface due to the hydration and partial solubilization of the water soluble polymer layer.
  • the whitening agent that is dispersed throughout this polymeric layer is then activated as it comes in contact with saliva and is released to the underlying surface.
  • the erosion rate of the device is controlled by the coated backing layer, which affects the amount of time the whitening agent remains in contact with the enamel surface.
  • the main purpose of the backing layer is to slow down the dissolution of the water-soluble polymeric layer containing a whitening agent, and therefore maximizing the direct contact time and unidirectional delivery to the tooth surface.
  • the composition of the backing layer is easily adjusted to provide variable erosion rates from one half hour to several hours.
  • the layered device is essentially totally erodible, and therefore does not require removal after the appropriate treatment time.
  • the Residence Time as defined above is difficult to quantitatively ascertain.
  • One visual method is to apply the layered device to the teeth surface and periodically observe the covered surface using a mirror and assess approximately how much residue remains on the surface.
  • the adhesive swells and starts to dissolve and fall off the teeth surface.
  • the actual residence time on each surface is controlled primarily by the flow of saliva to the surface and any friction created by interaction with the internal surface of the lips.
  • the polymeric coating layer that adheres to the tooth enamel is composed of one or more adhesive polymers, an appropriate whitening agent and a plasticizer. This coating may also contain an antioxidant, a preservative and a taste-masking flavor.
  • the adhesive polymers can be any water soluble, FDA approved polymer for oral applications that sticks to an enamel surface when in contact with a moist tooth surface.
  • the adhesive polymers may comprise hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, hydroxyethylmethyl cellulose, sodium carboxymethyl cellulose, polyvinyl pyrrolidone, polyvinyl alcohol, polyethylene glycol, polyacrylic acid, polyethylene oxide, alone or in combination thereof.
  • the preferred adhesive polymers are hydroxyethyl cellulose and polyvinyl pyrrolidone since they exhibit rapid and effective adhesion to enamel when in contact with a moist tooth surface.
  • the molecular weight of the adhesive polymer is also important, since it must be large enough so that an integral film can form, but not so large that immediate interfacial solubilization and adhesion to the enamel surface is impaired.
  • Typical average molecular weights range between 50,000 and 1,500,000 Daltons, and preferably between 50,000 and 500,000.
  • the whitening agents suitable for the practice of the present invention include peroxides, metal chlorites, perborates, percarbonates, peroxyacids, persulfates, alone or in combination thereof.
  • Suitable peroxide compounds include hydrogen peroxide, carbamide peroxide, calcium peroxide, and mixtures thereof.
  • the preferred peroxide is carbamide peroxide.
  • Suitable metal chlorites include calcium chlorite, barium chlorite, magnesium chlorite, lithium chlorite, sodium chlorite, and potassium chlorite.
  • the preferred chlorite is sodium chlorite.
  • a preferred percarbonate is sodium percarbonate, and the preferred persulfates are oxones.
  • the rate at which the whitening agent is solubilized and subsequently released to a tooth surface is controlled by varying the film thickness, polymer properties such as structure and molecular weight, type and properties of whitening agent and the concentration of the whitening agent.
  • the concentration of the whitening agent typically varies from about 0.1% to about 30% by weight of the total layered device, and preferably from about 0.5% to about 20% by weight.
  • a plasticizer useful for purposes of the present invention is selected from glycols such as propylene glycol, polyethylene glycol, polyhydric alcohols such as glycerin and sorbitol and glycerol esters such as glycerol triacetate.
  • the plasticizer comprises about 0.2% to about 30% by weight of the film of the present invention and preferably about 0.5% to about 10% by weight.
  • Glycerin and propylene glycol are the preferred plasticizers for use in the present invention as well as polyethylene glycol.
  • the preferred molecular weights for polyethylene glycol are in the range of 200-600 Daltons.
  • a colorant or opacifier can be incorporated in the adhesive layer or any of the layers of this device for use as an appearance enhancer.
  • the colorant or opacifier comprises about 0.01% to about 10% by weight of the film of the present invention and preferably about 0.03% to about 1% by weight. Colors and opacifiers may also be used to help distinguish the non-adhesive backing layer from the enamel adhering layer. Some opacifiers include titanium dioxide, zinc oxide, zirconium silicate and others.
  • a plasticizer, and colorants there may also be included in the adhesive film matrix a minor amount, e.g., 0.01 to 2% by weight, of ingredients such as preservatives, antioxidants, and flavors.
  • the backing layer solution is composed of a mixture of a hydrophobic polymer, such as ethyl cellulose, methyl cellulose, propyl cellulose or other related polymers and copolymers, anionic, cationic and neutral polymers and copolymers of methyl methacrylate under the trade name EUDRAGIT®, and a water soluble polymer such as polyvinyl pyrrolidone, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl alcohol or any other water soluble polymer that can be completely commixed with the hydrophobic polymer(s), dissolved in ethanol or other suitable organic solvent.
  • a hydrophobic polymer such as ethyl cellulose, methyl cellulose, propyl cellulose or other related polymers and copolymers, anionic, cationic and neutral polymers and copolymers of methyl methacrylate under the trade name EUDRAGIT®
  • a water soluble polymer such as
  • the ratio of the hydrophobic to the hydrophilic polymer is adjusted to increase or decrease the desired residence time that the device remains on the teeth before complete erosion.
  • the ratio of hydrophobic to hydrophilic polymer ranges from 0.5:1 to 10:1 by weight, and more preferably 1.5:1 to 3:1 by weight.
  • the backing layer solution may also contain a plasticizing agent, such as propylene glycol, polyethylene glycol, or glycerin, in a small amount, 0.1 to 2.0% by weight, in order to improve the flexibility and conformability of the resultant layered film and to adjust the erosion rate of the device.
  • a plasticizing agent such as propylene glycol, polyethylene glycol, or glycerin
  • Colors and opacifiers may also be added to help distinguish the non-adhesive backing layer from the enamel adhering layer.
  • these solutions are cast and processed into a thin film by techniques known in the art, such as by film dipping, film coating, film casting, spin coating, or spray drying. These films are produced on an appropriate support at the desired thickness and dried using an oven.
  • the primary support can be a polymer-coated paper, Mylar or any other appropriate non-deformable and impervious surface.
  • the preferable primary support is coated paper.
  • the primary support's casting surface must hold the film dimensionally stable during the coating and drying processes, but allow the resulting composite film to release when desired.
  • the actual casting surface for these solutions may be the primary support or another layer of the device being produced, such as the precast film layer or a freshly cast adhesive or backing layer.
  • the amount of coating solutions applied ranges between 0.01 to 1.5 mm, and most preferably between 0.05 and 0.4 mm for the backing layer and between 0.8 and 1.3 mm for the adhesive layer.
  • the amount of solids present in the coating solutions, the resulting solution viscosity and coating thickness applied determine the amount of coating film to be deposited on the casting surface.
  • the final layered device will consist of an adhesive layer and a hydrophobic layer with or without a precast hydroxypropylmethyl cellulose (HPMC) film in-between.
  • HPMC hydroxypropylmethyl cellulose
  • the adhesive layer is formed on an appropriate primary support.
  • the backing layer is formed on a water soluble, polymeric precast film of HPMC.
  • the two films are then laminated, with the hydrophobic layer either on the outside or in the middle of the final composite film, using an appropriate binding solution such as polyvinylpyrrolidone dissolved in a water/ethanol mixture.
  • This multi-layered film can be either peeled away from the primary support and cut into the desired shape or cut with the primary support still attached.
  • the backing layer is formed on an appropriate primary support.
  • a precast film of HPMC is then laminated to the backing layer using binding solution consisting of polyvinylpyrrolidone dissolved in a water/ethanol mixture.
  • binding solution consisting of polyvinylpyrrolidone dissolved in a water/ethanol mixture.
  • a distinct binding layer typically composed of polyvinylpyrrolidone is formed on top of the HPMC precast film.
  • the adhesive layer is formed on top of the binding layer. This resulting multi-layer film is then further processed as outlined above.
  • the adhesive layer is formed on an appropriate primary support by the casting methods previously described.
  • the backing layer is then formed directly on top of the adhesive layer. This two-layer film is then further processed as outlined above.
  • the backing layer is formed on an appropriate primary support by the casting methods previously described
  • the adhesive layer is then formed directly on top of the backing layer and the resulting bilayered product is further processed as outlined above.
  • each layer will affect the residence time of the device.
  • the hydrophobic layer composition and thickness are the most important parameters in controlling the residence time.
  • inclusion of the water soluble, polymeric precast film as one of the layers of the device will also increase the residence time, since the overall thickness of the device is increased.
  • the total thickness of the device is also an important consideration in regards to user acceptance. A very thick device becomes more noticeable with respect to “mouth feel”, and may cause the user to discontinue its use prematurely, thus compromising efficacy.
  • the total thickness of the device will also affect its ability to conform and adhere to teeth in an efficient manner.
  • thin films are preferred since they can be easily applied and bent around the teeth, minimizing the amount of unattached area in the form of edges and comers that could cause the film to be accidentally pulled off the teeth.
  • the film is too thin, it will begin to lose tensile strength and rip during its application.
  • the thickness of the adhesive layer is between 50 ⁇ and 300 ⁇ , and more preferably between 60 ⁇ and 140 ⁇ .
  • the thickness of the backing layer is between 50 ⁇ and 300 ⁇ , and more preferably between 60 ⁇ and 100 ⁇ .
  • the thickness of the precast layer if used to produce a multilayered device is between 25 ⁇ and 200 ⁇ , and more preferably between 50 ⁇ and 100 ⁇ .
  • the overall thickness of the device is between 75 ⁇ and 500 ⁇ , and more preferably between 125 ⁇ and 300 ⁇ .
  • a 180.0 gram batch of placebo adhesive solution was prepared using 10.0 grams hydroxyethyl cellulose (Natrosol 250L NF; Hercules), 10.0 grams polyvinyl pyrrolidone (PVP; Povidone P-1416; Spectrum), 0.65 grams sodium benzoate (Spectrum), 0.65 grams propylene glycol (Spectrum), and 158.7 grams deionized and 0.22 ⁇ -filtered water. This solution was used in Example 11 below.
  • a 29.87 gram batch of active adhesive solution was prepared using 4.37 grams hydroxyethyl cellulose (Natrosol 250L NF; Hercules), 1.80 grams PVP (Povidone P-1416; Spectrum), 0.09 grams sodium benzoate (Spectrum), 0.09 grams propylene glycol (Spectrum), 2.70 grams carbamide peroxide (Spectrum), and 20.82 grams deionized and 0.22 ⁇ -filtered water. This solution was used in Examples 12 and 13 below.
  • a 25.94 gram batch of active adhesive solution was prepared using 3.51 grams hydroxyethyl cellulose (Natrosol 250L NF; Hercules), 1.66 grams PVP (Povidone P-1416; Spectrum), 0.08 grams sodium benzoate (Spectrum), 0.08 grams propylene glycol (Spectrum), 2.49 grams carbamide peroxide (Spectrum), and 18.12 grams deionized and 0.22 ⁇ -filtered water. This solution was used in Examples 14 and 15 below.
  • a 46.84 gram batch of active adhesive solution was prepared using 2.70 grams hydroxyethyl cellulose (Natrosol 250L NF; Hercules), 1.35 grams PVP (Povidone P-1416; Spectrum), 0.15 grams sodium benzoate (Spectrum), 0.15 grams propylene glycol (Spectrum), 2.70 grams carbamide peroxide (Spectrum), 1.95 grams sodium alginate, and 37.84 grams deionized and 0.22 ⁇ -filtered water. This solution was used in Examples 16 and 17 below.
  • a 19.0 gm batch of backing solution was prepared using 2.0 grams of ethyl cellulose (Ethocel Premium Std 7; Dow Chemical), 1.0 grams of HPMC (Methocel E5 Prem LV; Dow Chemical), 1.0 gram Adams Extract Red Food Color, and 15.0 grams ethanol (190 proof; USP; Spectrum).
  • This backing solution was used in Examples 11, 15, and 18 below.
  • a 16.5 gram batch of backing solution was prepared using 1.1 grams of ethyl cellulose, 1.1 grams of HPMC, 0.9 grams Adams Extract Red Food Color, and 13.4 grams ethanol (190 proof, USP; Spectrum). This backing solution was used to make Examples 16 and 17 below.
  • a 19.8 gram batch of backing solution was prepared using 2.2 grams of ethyl cellulose, 1.1 grams of HPMC, and 16.5 grams ethanol (190 proof, USP; Spectrum). This backing solution was used to make Examples 12, 13, 19, and 20 below.
  • a 25.2 gram batch of backing solution was prepared using 1.8 grams of ethyl cellulose, 1.8 grams of HPMC, and 21.6 grams ethanol (190 proof, USP; Spectrum). This backing solution was used to make Examples 21 and 22 below.
  • a 52.7 gram batch of laminating solution was prepared using 6.32 grams PVP (P1416; Spectrum), 23.19 grams ethanol (190 proof, USP; Spectrum), and 23.19 grams deionized and 0.22 ⁇ -filtered water.
  • the precast HPMC film used in several embodiments of this device was typically a 100 ⁇ thick sheet called EM1100 from Polymer Films. In some embodiments, it was stretched on a paper-and-foil frame of a Werner Mathis AG Lab Coater, type LTF, and a backing solution selected from Examples 5-8 was poured on top and doctor-bladed at a 0.25 mm setting, then dried in the oven section of the Lab Coater.
  • a composite device was made by doctor-blading the adhesive solution of Example 1 into a film using the Lab Coater.
  • the casting was performed on a polymer-coated paper from Fortifiber, which was put on the paper and foil frame of the Lab Coater, with a doctor blade setting of 1.76 mm.
  • the film was automatically dried in the oven portion of the Lab Coater, and a smooth, integral layer of deposited, adhesive polymer resulted.
  • a layer of backing solution from Example 5 was doctor-bladed on top of the precast HPMC film (Example 10) using a 0.25 mm setting.
  • the two films were then laminated together using the laminating solution described in Example 9 and pressure from a roller, followed by drying in the Lab Coater oven.
  • the film was cut either before or after removal from the coated paper and upon application to a moist tooth surface, the film stuck well.
  • a composite device was made as in Example 11, except using the adhesive of Example 2, with doctor-blade setting of 1.00 mm, and the backing solution of Example 7. After cutting and removal from the casting coated paper, the resulting film also stuck well to teeth.
  • Another composite device was made by putting a backing layer of 2:1 ethyl cellulose to HPMC as described in Example 7 on polymer-coated paper (from Fortifiber) and then putting a layer of whitening adhesive (Example 2) on top of it.
  • the backing layer was doctor-bladed at a 0.43 mm setting and the adhesive was doctor-bladed at a setting of 1.30 mm. This film after removal from the paper and cutting, stuck immediately and firmly to teeth, conformed extremely well, and eroded away without notice.
  • a composite device composed of only an adhesive layer was made using the process outlined in Example 11, except the adhesive of Example 3 was used and with a doctor blade setting of 1.30 mm.
  • a test was done to determine the whitening efficacy of this adhesive layer alone as compared to the competitive product Crest Whitestrips. Both products were dampened and pressed onto a coffee-stained white cup. They were removed after 16 hours. The amount of whitening was compared and ranked by eight individuals who did not know which device did which whitening. The results shown below indicate that the adhesive layer containing a whitening agent is as effective if not better than one competitive product.
  • Adhesive only: 5 firsts, 1 tie, and 2 seconds; relative average score 1.38
  • a composite device was made by putting a layer of active adhesive from Example 3 on a polymer-coated paper (Fortifiber) and then putting a layer of backing solution from Example 5 on top of it.
  • the adhesive was doctor-bladed at settings of 1.30 mm.
  • the backing layer was spread thinly onto the surface of the dried adhesive film using a spatula and then dried. This resulting film after removal from the coated paper stuck well to the teeth.
  • a composite device was made as in Example 11, except using the adhesive of Example 4 and with a doctor blade setting of 1.30 mm and the backing solution of Example 6 with a doctor blade setting of 0.25 mm. A strip of this film after removal from the surface of the coated paper and cutting, lasted about 11 ⁇ 2 hours on the front teeth.
  • a composite device was made as in Example 15, except using the adhesive of Example 4 and the backing solution of Example 6. A strip of this film after removal from the surface of the coated paper and cutting, lasted about 1 hour on the front teeth.
  • a composite device was made as in Example 11, except using the adhesive of Example 3 without the tooth whitening agent, carbamide peroxide, and doctor blade settings of 1.30 mm. After processing, this placebo film visually seemed similar to the active films and upon removal from the coated paper and cutting, stuck comparably to the teeth.
  • a composite device was made as in Example 11, except using the adhesive of Example 4, a doctor blade setting of 1.30 mm, and the backing solution of Example 7.
  • a composite device was made as in Example 15, except using the adhesive of Example 4, with a doctor blade setting of 1.30 mm, and the backing solution of Example 7. The resulting film after removal from the coated paper and cutting, lasted more than 1 ⁇ 2 hour on the front teeth.
  • a composite device was made as in Example 11, except using the adhesive of Example 4, with doctor blade setting of 1.30 mm, and the backing solution of Example 8. The resulting film after removal from the coated paper and cutting, lasted about 11 ⁇ 2 hours on the front teeth.
  • a composite device was made as in Example 15, except using the adhesive of Example 4, with doctor blade setting of 1.30 mm, and the backing solution of Example 8. The resulting film, after removal from the coated paper and cutting, lasted about 1 hour on the front teeth.

Abstract

A thin, flexible, bilayer or multi-layer film which when applied to teeth surfaces adheres and delivers an active compound to the underlying surface and erodes at a predetermined rate. The amount of time that the active agent remains in contact with the teeth surfaces is controlled by the composition of backing layer of the composite film. This erosion or residence time can be regulated one half hour to three hours, depending upon the desired therapeutic or cosmetic application.

Description

  • This application is a continuation-in-part and is based on and claims priority from U.S. patent application Ser. No. 09/931,319, filed Aug. 16, 2001 and is incorporated herein by reference.[0001]
  • FIELD OF THE INVENTION
  • This invention relates to the cosmetic or therapeutic treatment of teeth, and more specifically to an adherent, erodible film that provides an active ingredient agent to teeth surfaces for a prolonged and controlled period of time. [0002]
  • BACKGROUND OF THE INVENTION
  • A tooth is composed of a protective, hard enamel outer layer and an inner dentin layer. The enamel layer is typically opaque white or slightly off-white in color. This layer is composed of hydroxyapatite mineral crystals and is somewhat porous, allowing staining agents and discoloring substances to permeate the enamel and discolor teeth. In particular, certain foods, tobacco products and liquids such as tea and coffee tend to stain teeth. These substances accumulate on the surface and form a film on the teeth, and will then permeate into the enamel layer. This problem occurs over many years, imparting a noticeable discoloration of the enamel layer. [0003]
  • There have been numerous methods in the prior art relating to teeth whitening, including brushing the teeth using dentifrices containing an effective oxidizing agent such as peroxide. These types of compositions are disclosed in U.S. Pat. No. 5,256,402. More recently, several over-the-counter teeth whitening systems have become available and have gained in popularity as an alternative cosmetic treatment to teeth whitening procedures conducted by a professional. One such product is comprised of a thin strip of plastic film that has a tooth whitening composition applied to the surface as described in U.S. Pat. Nos. 5,894,017, 5,891,453 and 6,045,811. In addition, U.S. Pat No. 6,419,906 B1 describes a flexible film which when applied to stained teeth is hydrated by saliva and is effective in such form to whiten teeth. The film comprises an anhydrous water hydratable ethylene oxide polymer matrix containing a solid peroxide whitening agent whereby, upon placing and positioning on stained teeth, the peroxide is solubilized and activated by the saliva present in the oral cavity. These aforementioned systems produce a whitening effect when applied to stained teeth; however, the strips must be removed after a specified period of time. U.S. patent application Ser. No. 09/931,319 teaches the administration of pharmaceutically active compounds using a multi-layered mucoadhesive erodible drug delivery device. Although this reference relates to an oral pharmaceutical application unrelated to teeth whitening, one important teaching is that the length of time the device remains on the mucosal surface before complete erosion, the “residence time”, is easily modified by alterations of the backing layer. It is this teaching that will be utilized and adapted to the present invention relating to an erodible tooth-whitening strip. In the area of cosmetic dentistry, there is an ongoing need to improve the whitening efficiency and to provide more user-friendly over-the-counter products. [0004]
  • SUMMARY OF THE INVENTION
  • One object of the present invention is to provide a novel, cost-effective, erodible, layered device that adheres to the moist surfaces of teeth and delivers an active agent for a controlled period of time. Another object of the present invention is to provide a convenient, user-friendly, erodible, layered device that adheres to the moist teeth surfaces and delivers a tooth whitening agent to the underlying stained surfaces. A further object of this invention is to provide a tooth whitening device that is easily applied without breaking or leaving any unwanted residue on the hands. A further object of the present invention is to provide a flexible, layered device that conforms and adheres intimately and securely to the entire tooth surface, minimizing the exposure of any excess whitening agent to the surrounding gums as found with other competitive products. [0005]
  • The composition of the bi-layered and multi-layered devices consists of an enamel adherent, water soluble, polymeric layer containing a tooth whitening agent or other active compound and a coated, erodible backing layer that controls the desired residence time. Since the devices of the current invention can provide a longer contact time with a stained tooth surface before eroding, it is expected that lower and safer amounts of whitening agents can be used to accomplish similar or superior results than attained by other commercial products. [0006]
  • An important aspect of the present invention is an erodible multilayered strip comprising at least two layers, a first layer comprises a water soluble polymer or combination of polymers that adheres to moist enamel surfaces. A second layer is water erodible and controls the residence time that the strip remains adhere to the enamel surface. This erodible strip is preferably shaped to conform to an individual tooth or a row of teeth. [0007]
  • An important embodiment of the present invention involves erodible adhesive a mucoadhesive, erodible multi-layered device comprising a first, water-soluble adhesive layer to be placed in contact with a mucosal surface and a second, water-erodible non-adhesive backing layer that controls residence time of the device. The first layer preferably comprises a tooth-whitening agent, at least one water-soluble film-forming polymer in combination with at least one mucoadhesive polymer; and said second, water-erodible non-adhesive backing layer comprises a precast film containing at least one of hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl alcohol, polyethylene glycol, polyethylene oxide, and ethylene oxide-propylene oxide co-polymer, said backing layer being coated with at least one hydrophobic polymer, alone or in combination with at least one hydrophilic polymer, such that the backing layer is bioerodible. [0008]
  • An important aspect of the present invention is a mucoadhesive, erodible multi-layered device comprising a first, water-soluble adhesive layer to be placed in contact with a mucosal surface and a second, water-erodible non-adhesive backing layer that controls residence time of the device. The first layer comprises a tooth-whitening agent (most preferably carbamide peroxide), at least one water-soluble film-forming polymer in combination with at least one mucoadhesive polymer. Said second, water-erodible non-adhesive backing layer comprises a precast film containing at least one of hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl alcohol, polyethylene glycol, polyethylene oxide, and ethylene oxide-propylene oxide co-polymer. This backing layer is coated with at least one hydrophobic polymer, alone or in combination with at least one hydrophilic polymer, such that the backing layer is bioerodible. The second water-erodible non-adhesive backing layer acts as a casting and support surface on which the adhesive layer is prepared. It preferably, and comprises a premade film of hydroxypropyl methyl cellulose in combination with a coating consisting of at least one hydrophobic polymer selected from the family of quaternary ammonium acrylate/methacrylate co-polymers, (Eudragit RS) ethyl cellulose and methyl cellulose, alone or in combination with at least one hydrophilic polymer, selected from the group consisting of polyvinyl pyrrolidone, hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, and polyvinyl alcohol. [0009]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • In the present invention, a unique, erodible, layered device that adheres to tooth enamel surfaces is provided. The device is most applicable for the cosmetic treatment of stained teeth, by delivering a whitening agent or combination of agents thereof for a controlled period of time. The device can also be used for the delivery of fluoride ions and phosphates for the preventative treatment of caries and tartar accumulation, respectively. [0010]
  • The device initially adheres to a moist tooth surface due to the hydration and partial solubilization of the water soluble polymer layer. The whitening agent that is dispersed throughout this polymeric layer is then activated as it comes in contact with saliva and is released to the underlying surface. The erosion rate of the device is controlled by the coated backing layer, which affects the amount of time the whitening agent remains in contact with the enamel surface. The main purpose of the backing layer is to slow down the dissolution of the water-soluble polymeric layer containing a whitening agent, and therefore maximizing the direct contact time and unidirectional delivery to the tooth surface. The composition of the backing layer is easily adjusted to provide variable erosion rates from one half hour to several hours. The layered device is essentially totally erodible, and therefore does not require removal after the appropriate treatment time. [0011]
  • The Residence Time as defined above is difficult to quantitatively ascertain. One visual method is to apply the layered device to the teeth surface and periodically observe the covered surface using a mirror and assess approximately how much residue remains on the surface. Typically, as the backing layer erodes away at a predetermined rate, the adhesive swells and starts to dissolve and fall off the teeth surface. The actual residence time on each surface is controlled primarily by the flow of saliva to the surface and any friction created by interaction with the internal surface of the lips. [0012]
  • The polymeric coating layer that adheres to the tooth enamel is composed of one or more adhesive polymers, an appropriate whitening agent and a plasticizer. This coating may also contain an antioxidant, a preservative and a taste-masking flavor. [0013]
  • The adhesive polymers can be any water soluble, FDA approved polymer for oral applications that sticks to an enamel surface when in contact with a moist tooth surface. The adhesive polymers may comprise hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, hydroxyethylmethyl cellulose, sodium carboxymethyl cellulose, polyvinyl pyrrolidone, polyvinyl alcohol, polyethylene glycol, polyacrylic acid, polyethylene oxide, alone or in combination thereof. The preferred adhesive polymers are hydroxyethyl cellulose and polyvinyl pyrrolidone since they exhibit rapid and effective adhesion to enamel when in contact with a moist tooth surface. [0014]
  • The molecular weight of the adhesive polymer is also important, since it must be large enough so that an integral film can form, but not so large that immediate interfacial solubilization and adhesion to the enamel surface is impaired. Typical average molecular weights range between 50,000 and 1,500,000 Daltons, and preferably between 50,000 and 500,000. [0015]
  • The whitening agents suitable for the practice of the present invention include peroxides, metal chlorites, perborates, percarbonates, peroxyacids, persulfates, alone or in combination thereof. Suitable peroxide compounds include hydrogen peroxide, carbamide peroxide, calcium peroxide, and mixtures thereof. The preferred peroxide is carbamide peroxide. Suitable metal chlorites include calcium chlorite, barium chlorite, magnesium chlorite, lithium chlorite, sodium chlorite, and potassium chlorite. The preferred chlorite is sodium chlorite. A preferred percarbonate is sodium percarbonate, and the preferred persulfates are oxones. [0016]
  • The rate at which the whitening agent is solubilized and subsequently released to a tooth surface is controlled by varying the film thickness, polymer properties such as structure and molecular weight, type and properties of whitening agent and the concentration of the whitening agent. The concentration of the whitening agent typically varies from about 0.1% to about 30% by weight of the total layered device, and preferably from about 0.5% to about 20% by weight. [0017]
  • A plasticizer useful for purposes of the present invention is selected from glycols such as propylene glycol, polyethylene glycol, polyhydric alcohols such as glycerin and sorbitol and glycerol esters such as glycerol triacetate. The plasticizer comprises about 0.2% to about 30% by weight of the film of the present invention and preferably about 0.5% to about 10% by weight. [0018]
  • Glycerin and propylene glycol are the preferred plasticizers for use in the present invention as well as polyethylene glycol. The preferred molecular weights for polyethylene glycol are in the range of 200-600 Daltons. [0019]
  • A colorant or opacifier can be incorporated in the adhesive layer or any of the layers of this device for use as an appearance enhancer. The colorant or opacifier comprises about 0.01% to about 10% by weight of the film of the present invention and preferably about 0.03% to about 1% by weight. Colors and opacifiers may also be used to help distinguish the non-adhesive backing layer from the enamel adhering layer. Some opacifiers include titanium dioxide, zinc oxide, zirconium silicate and others. [0020]
  • In addition to the incorporation of whitening agents, a plasticizer, and colorants, there may also be included in the adhesive film matrix a minor amount, e.g., 0.01 to 2% by weight, of ingredients such as preservatives, antioxidants, and flavors. [0021]
  • The backing layer solution is composed of a mixture of a hydrophobic polymer, such as ethyl cellulose, methyl cellulose, propyl cellulose or other related polymers and copolymers, anionic, cationic and neutral polymers and copolymers of methyl methacrylate under the trade name EUDRAGIT®, and a water soluble polymer such as polyvinyl pyrrolidone, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl alcohol or any other water soluble polymer that can be completely commixed with the hydrophobic polymer(s), dissolved in ethanol or other suitable organic solvent. The ratio of the hydrophobic to the hydrophilic polymer is adjusted to increase or decrease the desired residence time that the device remains on the teeth before complete erosion. The ratio of hydrophobic to hydrophilic polymer ranges from 0.5:1 to 10:1 by weight, and more preferably 1.5:1 to 3:1 by weight. [0022]
  • The backing layer solution may also contain a plasticizing agent, such as propylene glycol, polyethylene glycol, or glycerin, in a small amount, 0.1 to 2.0% by weight, in order to improve the flexibility and conformability of the resultant layered film and to adjust the erosion rate of the device. Colors and opacifiers may also be added to help distinguish the non-adhesive backing layer from the enamel adhering layer. [0023]
  • Once dissolved, these solutions (adhesive and backing) are cast and processed into a thin film by techniques known in the art, such as by film dipping, film coating, film casting, spin coating, or spray drying. These films are produced on an appropriate support at the desired thickness and dried using an oven. The primary support can be a polymer-coated paper, Mylar or any other appropriate non-deformable and impervious surface. The preferable primary support is coated paper. The primary support's casting surface must hold the film dimensionally stable during the coating and drying processes, but allow the resulting composite film to release when desired. The actual casting surface for these solutions may be the primary support or another layer of the device being produced, such as the precast film layer or a freshly cast adhesive or backing layer. The amount of coating solutions applied, using a suitable doctor blade or lab coater apparatus, ranges between 0.01 to 1.5 mm, and most preferably between 0.05 and 0.4 mm for the backing layer and between 0.8 and 1.3 mm for the adhesive layer. The amount of solids present in the coating solutions, the resulting solution viscosity and coating thickness applied determine the amount of coating film to be deposited on the casting surface. [0024]
  • The final layered device will consist of an adhesive layer and a hydrophobic layer with or without a precast hydroxypropylmethyl cellulose (HPMC) film in-between. A precast water soluble film between the adhesive and backing layers will typically provide a longer residence time on the teeth. Several methods of forming this device are now provided herein. [0025]
  • In one embodiment, the adhesive layer is formed on an appropriate primary support. In a separate operation, the backing layer is formed on a water soluble, polymeric precast film of HPMC. The two films are then laminated, with the hydrophobic layer either on the outside or in the middle of the final composite film, using an appropriate binding solution such as polyvinylpyrrolidone dissolved in a water/ethanol mixture. This multi-layered film can be either peeled away from the primary support and cut into the desired shape or cut with the primary support still attached. [0026]
  • In another embodiment, the backing layer is formed on an appropriate primary support. A precast film of HPMC is then laminated to the backing layer using binding solution consisting of polyvinylpyrrolidone dissolved in a water/ethanol mixture. Then a distinct binding layer, typically composed of polyvinylpyrrolidone is formed on top of the HPMC precast film. Finally, the adhesive layer is formed on top of the binding layer. This resulting multi-layer film is then further processed as outlined above. [0027]
  • In a preferred embodiment, the adhesive layer is formed on an appropriate primary support by the casting methods previously described. The backing layer is then formed directly on top of the adhesive layer. This two-layer film is then further processed as outlined above. [0028]
  • In another preferred embodiment, the backing layer is formed on an appropriate primary support by the casting methods previously described The adhesive layer is then formed directly on top of the backing layer and the resulting bilayered product is further processed as outlined above. [0029]
  • The thicknesses of each layer will affect the residence time of the device. The hydrophobic layer composition and thickness are the most important parameters in controlling the residence time. However, inclusion of the water soluble, polymeric precast film as one of the layers of the device will also increase the residence time, since the overall thickness of the device is increased. [0030]
  • The total thickness of the device is also an important consideration in regards to user acceptance. A very thick device becomes more noticeable with respect to “mouth feel”, and may cause the user to discontinue its use prematurely, thus compromising efficacy. [0031]
  • The total thickness of the device will also affect its ability to conform and adhere to teeth in an efficient manner. Typically, thin films are preferred since they can be easily applied and bent around the teeth, minimizing the amount of unattached area in the form of edges and comers that could cause the film to be accidentally pulled off the teeth. However, if the film is too thin, it will begin to lose tensile strength and rip during its application. [0032]
  • With respect to the individual layers of the composite film, the thickness of the adhesive layer is between 50μ and 300μ, and more preferably between 60μ and 140μ. The thickness of the backing layer is between 50μ and 300μ, and more preferably between 60μ and 100μ. The thickness of the precast layer if used to produce a multilayered device is between 25μ and 200μ, and more preferably between 50μ and 100μ. The overall thickness of the device is between 75μ and 500μ, and more preferably between 125μ and 300μ.[0033]
  • EXAMPLE 1
  • A 180.0 gram batch of placebo adhesive solution was prepared using 10.0 grams hydroxyethyl cellulose (Natrosol 250L NF; Hercules), 10.0 grams polyvinyl pyrrolidone (PVP; Povidone P-1416; Spectrum), 0.65 grams sodium benzoate (Spectrum), 0.65 grams propylene glycol (Spectrum), and 158.7 grams deionized and 0.22μ-filtered water. This solution was used in Example 11 below. [0034]
  • EXAMPLE 2
  • A 29.87 gram batch of active adhesive solution was prepared using 4.37 grams hydroxyethyl cellulose (Natrosol 250L NF; Hercules), 1.80 grams PVP (Povidone P-1416; Spectrum), 0.09 grams sodium benzoate (Spectrum), 0.09 grams propylene glycol (Spectrum), 2.70 grams carbamide peroxide (Spectrum), and 20.82 grams deionized and 0.22μ-filtered water. This solution was used in Examples 12 and 13 below. [0035]
  • EXAMPLE 3
  • A 25.94 gram batch of active adhesive solution was prepared using 3.51 grams hydroxyethyl cellulose (Natrosol 250L NF; Hercules), 1.66 grams PVP (Povidone P-1416; Spectrum), 0.08 grams sodium benzoate (Spectrum), 0.08 grams propylene glycol (Spectrum), 2.49 grams carbamide peroxide (Spectrum), and 18.12 grams deionized and 0.22μ-filtered water. This solution was used in Examples 14 and 15 below. [0036]
  • EXAMPLE 4
  • A 46.84 gram batch of active adhesive solution was prepared using 2.70 grams hydroxyethyl cellulose (Natrosol 250L NF; Hercules), 1.35 grams PVP (Povidone P-1416; Spectrum), 0.15 grams sodium benzoate (Spectrum), 0.15 grams propylene glycol (Spectrum), 2.70 grams carbamide peroxide (Spectrum), 1.95 grams sodium alginate, and 37.84 grams deionized and 0.22μ-filtered water. This solution was used in Examples 16 and 17 below. [0037]
  • EXAMPLE 5
  • A 19.0 gm batch of backing solution was prepared using 2.0 grams of ethyl cellulose (Ethocel Premium Std 7; Dow Chemical), 1.0 grams of HPMC (Methocel E5 Prem LV; Dow Chemical), 1.0 gram Adams Extract Red Food Color, and 15.0 grams ethanol (190 proof; USP; Spectrum). This backing solution was used in Examples 11, 15, and 18 below. [0038]
  • EXAMPLE 6
  • A 16.5 gram batch of backing solution was prepared using 1.1 grams of ethyl cellulose, 1.1 grams of HPMC, 0.9 grams Adams Extract Red Food Color, and 13.4 grams ethanol (190 proof, USP; Spectrum). This backing solution was used to make Examples 16 and 17 below. [0039]
  • EXAMPLE 7
  • A 19.8 gram batch of backing solution was prepared using 2.2 grams of ethyl cellulose, 1.1 grams of HPMC, and 16.5 grams ethanol (190 proof, USP; Spectrum). This backing solution was used to make Examples 12, 13, 19, and 20 below. [0040]
  • EXAMPLE 8
  • A 25.2 gram batch of backing solution was prepared using 1.8 grams of ethyl cellulose, 1.8 grams of HPMC, and 21.6 grams ethanol (190 proof, USP; Spectrum). This backing solution was used to make Examples 21 and 22 below. [0041]
  • EXAMPLE 9
  • A 52.7 gram batch of laminating solution was prepared using 6.32 grams PVP (P1416; Spectrum), 23.19 grams ethanol (190 proof, USP; Spectrum), and 23.19 grams deionized and 0.22μ-filtered water. [0042]
  • EXAMPLE 10
  • The precast HPMC film used in several embodiments of this device was typically a 100μ thick sheet called EM1100 from Polymer Films. In some embodiments, it was stretched on a paper-and-foil frame of a Werner Mathis AG Lab Coater, type LTF, and a backing solution selected from Examples 5-8 was poured on top and doctor-bladed at a 0.25 mm setting, then dried in the oven section of the Lab Coater. [0043]
  • EXAMPLE 11
  • A composite device was made by doctor-blading the adhesive solution of Example 1 into a film using the Lab Coater. The casting was performed on a polymer-coated paper from Fortifiber, which was put on the paper and foil frame of the Lab Coater, with a doctor blade setting of 1.76 mm. The film was automatically dried in the oven portion of the Lab Coater, and a smooth, integral layer of deposited, adhesive polymer resulted. Then, separately, a layer of backing solution from Example 5 was doctor-bladed on top of the precast HPMC film (Example 10) using a 0.25 mm setting. The two films were then laminated together using the laminating solution described in Example 9 and pressure from a roller, followed by drying in the Lab Coater oven. The film was cut either before or after removal from the coated paper and upon application to a moist tooth surface, the film stuck well. [0044]
  • EXAMPLE 12
  • A composite device was made as in Example 11, except using the adhesive of Example 2, with doctor-blade setting of 1.00 mm, and the backing solution of Example 7. After cutting and removal from the casting coated paper, the resulting film also stuck well to teeth. [0045]
  • EXAMPLE 13
  • Another composite device was made by putting a backing layer of 2:1 ethyl cellulose to HPMC as described in Example 7 on polymer-coated paper (from Fortifiber) and then putting a layer of whitening adhesive (Example 2) on top of it. The backing layer was doctor-bladed at a 0.43 mm setting and the adhesive was doctor-bladed at a setting of 1.30 mm. This film after removal from the paper and cutting, stuck immediately and firmly to teeth, conformed extremely well, and eroded away without notice. [0046]
  • EXAMPLE 14
  • A composite device composed of only an adhesive layer was made using the process outlined in Example 11, except the adhesive of Example 3 was used and with a doctor blade setting of 1.30 mm. A test was done to determine the whitening efficacy of this adhesive layer alone as compared to the competitive product Crest Whitestrips. Both products were dampened and pressed onto a coffee-stained white cup. They were removed after 16 hours. The amount of whitening was compared and ranked by eight individuals who did not know which device did which whitening. The results shown below indicate that the adhesive layer containing a whitening agent is as effective if not better than one competitive product. [0047]
  • Adhesive only: 5 firsts, 1 tie, and 2 seconds; relative average score=1.38 [0048]
  • Crest White Strip: 2 first, 1 tie, and 5 seconds; relative average score=1.75 [0049]
  • EXAMPLE 15
  • A composite device was made by putting a layer of active adhesive from Example 3 on a polymer-coated paper (Fortifiber) and then putting a layer of backing solution from Example 5 on top of it. The adhesive was doctor-bladed at settings of 1.30 mm. The backing layer was spread thinly onto the surface of the dried adhesive film using a spatula and then dried. This resulting film after removal from the coated paper stuck well to the teeth. [0050]
  • EXAMPLE 16
  • A composite device was made as in Example 11, except using the adhesive of Example 4 and with a doctor blade setting of 1.30 mm and the backing solution of Example 6 with a doctor blade setting of 0.25 mm. A strip of this film after removal from the surface of the coated paper and cutting, lasted about 1½ hours on the front teeth. [0051]
  • EXAMPLE 17
  • A composite device was made as in Example 15, except using the adhesive of Example 4 and the backing solution of Example 6. A strip of this film after removal from the surface of the coated paper and cutting, lasted about 1 hour on the front teeth. [0052]
  • EXAMPLE 18
  • A composite device was made as in Example 11, except using the adhesive of Example 3 without the tooth whitening agent, carbamide peroxide, and doctor blade settings of 1.30 mm. After processing, this placebo film visually seemed similar to the active films and upon removal from the coated paper and cutting, stuck comparably to the teeth. [0053]
  • EXAMPLE 19
  • A composite device was made as in Example 11, except using the adhesive of Example 4, a doctor blade setting of 1.30 mm, and the backing solution of Example 7. [0054]
  • EXAMPLE 20
  • A composite device was made as in Example 15, except using the adhesive of Example 4, with a doctor blade setting of 1.30 mm, and the backing solution of Example 7. The resulting film after removal from the coated paper and cutting, lasted more than ½ hour on the front teeth. [0055]
  • EXAMPLE 21
  • A composite device was made as in Example 11, except using the adhesive of Example 4, with doctor blade setting of 1.30 mm, and the backing solution of Example 8. The resulting film after removal from the coated paper and cutting, lasted about 1½ hours on the front teeth. [0056]
  • EXAMPLE 22
  • A composite device was made as in Example 15, except using the adhesive of Example 4, with doctor blade setting of 1.30 mm, and the backing solution of Example 8. The resulting film, after removal from the coated paper and cutting, lasted about 1 hour on the front teeth. [0057]
  • Those skilled in the art will recognize that, while specific embodiments and examples have been described, various modifications and changes may be made without departing from the scope and spirit of this invention. [0058]

Claims (31)

1. An erodible strip comprising at least two layers, wherein one layer comprises a water soluble polymer or combination of polymers that adheres to moist enamel surfaces; and a second layer which is water erodible and controls the residence time that the strip remains adhered to the enamel surface.
2. The erodible strip of claim 1 being geometrically shaped as a strip to conform to an individual tooth or a row of teeth.
3. The strip of claim 2 wherein said water soluble polymer is at least one of polyvinyl pyrrolidone, polyvinyl alcohol, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, sodium carboxymethyl cellulose, polyethylene oxide, polyethylene glycol, and polyacrylic acid.
4. The strip of claim 2 wherein said first layer comprises a water soluble polymer or combination of polymers thereof and at least one tooth-whitening agent.
5. The strip of claim 4 wherein said tooth whitening agent is at least one selected from the group consisting of peroxides, metal chlorites, perborates, percarbonates, peroxyacids, and persulfates.
6. The strip of claim 4 wherein said tooth whitening agent is carbamide peroxide.
7. The strip of claim 2 wherein said second layer comprises a mixture of hydrophobic and water soluble polymers, consisting of either ethyl cellulose, methyl cellulose, or anionic, cationic and neutral polymers and copolymers of methacrylates under the trade name Eudragit®, alone or in combination thereof with at least one water soluble polymer selected from the group consisting of polyvinyl pyrrolidone, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, and polyvinyl alcohol.
8. The strip of claim 7 wherein said second layer comprises a mixture of hydrophobic and water soluble polymers at a ratio of 0.5:1 to 10:1 by weight.
9. The strip of claim 8 where the ratio is 1.5:1 to 3:1 by weight.
10. A strip film of claim 1 comprising a first layer consisting of a water soluble polymer or combination of polymers that adheres to moist enamel surfaces, a laminated middle layer comprising a precast film of a water soluble polymer, and a water erodible backing layer that controls the residence time that the film remains adhered to a tooth surface.
11. The strip of claim 10 defined as is geometrically shaped to conform to an individual tooth or a row of teeth.
12. The strip of claim 10 wherein the precast water soluble polymer is hydroxypropylmethyl cellulose.
13. The strip of claim 10 wherein said first layer comprises at least one water soluble polymer and at least one tooth whitening agent.
14. The strip of claim 10 wherein a laminating solution used to effectively bind the middle layer to the other two layers is composed of at least one water soluble polymer dissolved in alcohol, water, or an aqueous alcohol mixture.
15. The strip of claims 4 or 13 wherein said whitening agent is from 0.1% to 30% by weight of the strip.
16. The strip of claims 4 or 13 where said whitening agent is from 0.5% to 20% by weight.
17. The erodible teeth whitening strip of claims 2 or 11 defined further as containing propylene glycol, polyethylene glycol, glycerin, sorbitol, or glycerol acetate plasticizer at a concentration of 0.2% to 30% by weight.
18. The strip of claim 17 where the concentration is 0.5 to 10% by weight.
19. The erodible teeth whitening strip of claims 2 or 11 defined further as containing a titanium dioxide, zinc oxide or zirconium silicate colorant or opacifier as an appearance enhancer.
20. The strip of claim 19 where the appearance enhancer is at a concentration of 0.01% to 10% by weight.
21. The strip of claim 19 where the appearance enhancer is 0.03% to 1% by weight.
22. The erodible, teeth whitening strip of claims 2 and 11 defined further as containing at least one of a preservative, antioxidant, or flavor.
23. The strip of claim 19 where the appearance enhancer is at a concentration of 0.01% to 2% by weight.
24. The strip of claim 3 wherein said polymer is in a molecular weight range of between 25,000 and 1,500,000 Daltons.
25. The strip of claim 3 where said polymer is in a molecular weight range of 30,000 and 500,000 Daltons.
26. The strip of claims 2 or 11 wherein said first layer comprises at least one water soluble polymer and at least one compound that dissociates to release fluoride ions for the prevention of caries.
27. The strip of claims 2 or 11 wherein said first layer comprises at least one water soluble polymer and at least one phosphate compound for tartar control.
28. The strip of claims 2 or 11 wherein said first layer comprises at least one water soluble polymer and at least one ingredient that can cosmetically alters the appearance of teeth.
29. A mucoadhesive, erodible multi-layered device comprising a first, water-soluble adhesive layer to be placed in contact with a mucosal surface and a second, water-erodible non-adhesive backing layer that controls residence time of the device;
wherein said first layer comprises a tooth-whitening agent, at least one water-soluble film-forming polymer in combination with at least one mucoadhesive polymer; and said second, water-erodible non-adhesive backing layer comprises a precast film containing at least one of hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl alcohol, polyethylene glycol, polyethylene oxide, and ethylene oxide-propylene oxide co-polymer, said backing layer being coated with at least one hydrophobic polymer, alone or in combination with at least one hydrophilic polymer, such that the backing layer is bioerodible.
30. The mucoadhesive, erodible multi-layered device of claim 29, wherein said second water-erodible non-adhesive backing layer acts as a casting and support surface on which the adhesive layer is prepared, and comprises a premade film of hydroxypropyl methyl cellulose in combination with a coating consisting of at least one hydrophobic polymer selected from the family of quaternary ammonium acrylate/methacrylate co-polymers, (Eudragit RS) ethyl cellulose and methyl cellulose, alone or in combination with at least one hydrophilic polymer, selected from the group consisting of polyvinyl pyrrolidone, hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, and polyvinyl alcohol.
31. The device of claim 29 where the tooth-whitening agent is carbamide peroxide.
US10/444,512 2001-08-16 2003-05-23 Erodible film for treating the surfaces of teeth Abandoned US20040062724A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/444,512 US20040062724A1 (en) 2001-08-16 2003-05-23 Erodible film for treating the surfaces of teeth
US11/192,524 US20060073174A1 (en) 2001-08-16 2005-07-29 Adherent and erodible film to treat a moist surface of a body tissue

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/931,319 US6585997B2 (en) 2001-08-16 2001-08-16 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US10/444,512 US20040062724A1 (en) 2001-08-16 2003-05-23 Erodible film for treating the surfaces of teeth

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/931,319 Continuation-In-Part US6585997B2 (en) 2001-08-16 2001-08-16 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/192,524 Continuation-In-Part US20060073174A1 (en) 2001-08-16 2005-07-29 Adherent and erodible film to treat a moist surface of a body tissue

Publications (1)

Publication Number Publication Date
US20040062724A1 true US20040062724A1 (en) 2004-04-01

Family

ID=25460591

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/931,319 Expired - Lifetime US6585997B2 (en) 2001-08-16 2001-08-16 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US10/444,512 Abandoned US20040062724A1 (en) 2001-08-16 2003-05-23 Erodible film for treating the surfaces of teeth

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/931,319 Expired - Lifetime US6585997B2 (en) 2001-08-16 2001-08-16 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds

Country Status (16)

Country Link
US (2) US6585997B2 (en)
EP (1) EP1418889A2 (en)
JP (2) JP2005504763A (en)
KR (1) KR20040039290A (en)
CN (2) CN1738599A (en)
AU (1) AU2002326664B2 (en)
CA (1) CA2459692A1 (en)
HU (1) HUP0401281A3 (en)
IL (2) IL160419A0 (en)
IS (1) IS7155A (en)
MX (1) MXPA04001491A (en)
NZ (1) NZ531766A (en)
PL (1) PL373327A1 (en)
RU (1) RU2343903C2 (en)
WO (1) WO2003015748A2 (en)
ZA (1) ZA200402067B (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265245A1 (en) * 2003-05-27 2004-12-30 Allred Peter M. Substantially solid bleaching or treatment compositions in the form of inserts for dental trays, and kits comprising such inserts and trays
US20050072369A1 (en) * 2003-09-18 2005-04-07 Goossen Theodorus Jozef Submergible terrarium
US20050081760A1 (en) * 2003-07-01 2005-04-21 Leng Lu H. Table top
US20050100515A1 (en) * 2002-09-11 2005-05-12 The Procter & Gamble Company Tooth whitening products
US20050196354A1 (en) * 2004-03-03 2005-09-08 Andre Soshinsky Film compositions
US20050196348A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Stabilized peroxide compositions
US20050196358A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Film products having controlled disintegration properties
WO2005102254A1 (en) * 2004-04-08 2005-11-03 The Procter & Gamble Company Tooth whitening products
WO2005110344A1 (en) 2004-05-10 2005-11-24 Colgate-Palmolive Company Multilayer tooth whitening strips
US20050276760A1 (en) * 2004-06-09 2005-12-15 Lornamead Brands, Inc. Tooth for whitening products and methods of making the same
WO2006013081A1 (en) * 2004-08-02 2006-02-09 Glaxo Group Limited Novel composition for xerostomia
US20070003495A1 (en) * 1997-06-06 2007-01-04 The Procter & Gamble Company Methods for whitening teeth
US20070140985A1 (en) * 2005-12-21 2007-06-21 Boyd Thomas J Cleaning and/or Polishing Compositions and Methods of Use Thereof
US20070190125A1 (en) * 2004-03-03 2007-08-16 Constantine Georgiades Positioning feature for aiding use of film or strip product
US20070218015A1 (en) * 2003-11-03 2007-09-20 Craig Hardy Tooth-Whitening Composition
US20070269519A1 (en) * 2004-03-03 2007-11-22 Constantine Georgiades Whitening products
US20080003248A1 (en) * 2004-03-03 2008-01-03 Constantine Georgiades Whitening products
WO2008008617A2 (en) 2006-07-14 2008-01-17 Colgate-Palmolive Company Methods of making compositions comprising films
US20080286317A1 (en) * 2004-10-13 2008-11-20 Lts Lohmann Therapie-Systeme Ag Self-Adhesive Film for Teeth
WO2008157033A1 (en) * 2007-06-20 2008-12-24 Mcneil-Ppc, Inc Products for whitening teeth
USRE42126E1 (en) 1999-07-02 2011-02-08 The Procter & Gamble Company Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
US8137658B2 (en) 2005-06-28 2012-03-20 Isp Investments Inc. Tooth whitening compositions
WO2012064319A1 (en) 2010-11-08 2012-05-18 Colgate-Palmolive Company Oral compositions containing microaggregates
WO2012082101A1 (en) 2010-12-13 2012-06-21 Colgate-Palmolive Company Oral compositions and method for producing thereof
WO2012082103A1 (en) 2010-12-13 2012-06-21 Colgate-Palmolive Company Oral compositions and method for producing thereof
WO2012082098A1 (en) 2010-12-13 2012-06-21 Colgate-Palmolive Company Oral compositions and method for producing thereof
WO2013002505A1 (en) * 2011-06-27 2013-01-03 조선대학교 산학협력단 Tape-type fluorine preparation using a biodegradable polymer material, and method for producing same
RU2482836C1 (en) * 2009-04-02 2013-05-27 Колгейт-Палмолив Компани Consumer products changing colour
WO2013087623A2 (en) 2011-12-12 2013-06-20 Glaxo Group Limited Novel composition
US9554976B2 (en) 2002-09-11 2017-01-31 The Procter & Gamble Company Tooth whitening product

Families Citing this family (244)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646392A1 (en) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8728445B2 (en) 2001-05-01 2014-05-20 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Hydrogel Compositions
DE60239528D1 (en) 2001-05-01 2011-05-05 Corium International Redwood City TWO-PHASE, WATER-ABSORBING BIOADHESIVE COMPOSITION
US7727221B2 (en) 2001-06-27 2010-06-01 Cardiac Pacemakers Inc. Method and device for electrochemical formation of therapeutic species in vivo
US20030068375A1 (en) * 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US20110092677A1 (en) * 2001-08-30 2011-04-21 Biorexis Technology, Inc. Modified transferin-antibody fusion proteins
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US7201930B2 (en) * 2001-11-05 2007-04-10 Haley Jeffrey T Licorice root extract oral patch for treating canker sores
US20030099691A1 (en) * 2001-11-16 2003-05-29 Susan Lydzinski Films containing starch
US20030124178A1 (en) * 2001-12-28 2003-07-03 Haley Jeffrey T. Soft, adherent, soluble oral patch
US20030224090A1 (en) * 2002-02-11 2003-12-04 Edizone, Lc Snacks of orally soluble edible films
US7771707B2 (en) 2004-06-12 2010-08-10 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
US20040131662A1 (en) 2003-11-12 2004-07-08 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US8999372B2 (en) 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
CA2505833A1 (en) * 2002-11-14 2004-06-03 Innozen, Inc. Edible film for relief of cough or symptoms associated with pharyngitis
US20040191302A1 (en) 2003-03-28 2004-09-30 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US6669929B1 (en) 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
WO2004084870A1 (en) * 2003-03-28 2004-10-07 Sigmoid Biotechnologies Limited Solid oral dosage form containing seamless microcapsules
WO2004103328A1 (en) * 2003-04-30 2004-12-02 Icure Pharmaceutical Corporation Patch for tooth whitening
US7306812B2 (en) * 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7056118B2 (en) * 2003-05-27 2006-06-06 Ultradent Products, Inc. Compositions and devices having a tray-like configuration for delivering a medicament and methods of manufacturing and using such compositions and devices
US20040241151A1 (en) * 2003-05-27 2004-12-02 Sca Hygiene Products Ab Polymer matrix with lactic acid producing bacteria
US8313775B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2006528185A (en) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション Antibiotic preparations, their use and preparation
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
EP1653925A1 (en) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
JP2007502294A (en) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション Antibiotic preparations, their use and preparation
JP2007502823A (en) * 2003-08-15 2007-02-15 キューエルティー・ユーエスエイ・インコーポレーテッド Adhesive and bioerodible transmucosal drug delivery systems
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
JP2007513869A (en) 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション Antibiotic preparations, their use and preparation
CN1929819B (en) 2004-01-30 2012-02-29 考里安国际公司 Rapidly dissolving film for delivery of an active agent
US9925139B2 (en) * 2004-04-22 2018-03-27 Acucort Ab Pharmaceutical compositions for acute glucocorticoid therapy
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
WO2006014427A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
RU2393877C2 (en) 2004-08-05 2010-07-10 Кориум Интернэшнл, Инк. Adhesive composition
CA2518650A1 (en) * 2004-09-10 2006-03-10 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
PL1811979T3 (en) * 2004-09-27 2009-04-30 Sigmoid Pharma Ltd Microcapsules comprising a methylxanthine and a corticosteroid
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
WO2006036984A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Stand-alone film and methods for making the same
PE20060935A1 (en) 2004-10-21 2006-10-26 Novartis Ag PHARMACEUTICAL COMPOSITION INCLUDING DICLOFENACO
MX2007006908A (en) * 2004-12-09 2007-08-03 Bayer Healthcare Ag Stabilisation of glucocorticoid esters with acids.
US20060134201A1 (en) * 2004-12-16 2006-06-22 Haley Jeffrey T Collagen troches for treating mouth lesions
GB2421431B (en) * 2004-12-24 2007-10-10 Aquasol Ltd Dosing systems
DE102005015128B4 (en) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafers containing steroid hormones
WO2006135491A2 (en) 2005-06-08 2006-12-21 Basf Aktiengesellschaft Medicament carrier composition and method of forming a film therefrom
US20060281775A1 (en) 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain
PT2656860T (en) 2005-06-17 2021-07-28 Wisconsin Alumni Res Found Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) * 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
CA2612729C (en) * 2005-07-01 2018-02-27 Kane Biotech Inc. Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices
US20070042027A1 (en) * 2005-08-22 2007-02-22 Haley Jeffrey T Water soluble anesthetic in an oral patch of hydrophilic gums
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
KR20070057660A (en) * 2005-12-01 2007-06-07 롬 앤드 하아스 컴패니 Aqueous polymer dispersions for stabilizing actives
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
CA2629046C (en) * 2005-12-13 2014-04-08 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US9198865B2 (en) * 2006-01-19 2015-12-01 Dow Global Technologies Llc Biologically active composition comprising ethylcellulose
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US20070192182A1 (en) * 2006-02-10 2007-08-16 Tovin Monaco Method of delivering coupons using customer data
US20070192183A1 (en) * 2006-02-10 2007-08-16 Tovin Monaco System and architecture for providing retail buying options to consumer using customer data
US20070192438A1 (en) * 2006-02-10 2007-08-16 Esmond Goei System and method for on-demand delivery of media products
US20070190013A1 (en) * 2006-02-13 2007-08-16 Yeli Zhang Film and film-forming compositions
US8349120B2 (en) * 2006-03-07 2013-01-08 Ora Health Corporation Multi-layer patch made on a sheet and enclosed in a blister
EP2010366B1 (en) * 2006-03-24 2017-03-22 Auxilium International Holdings, Inc. Process for the preparation of a hot-melt extruded laminate
US8173152B2 (en) 2006-03-24 2012-05-08 Auxilium Us Holdings, Llc Stabilized compositions containing alkaline labile drugs
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US20070248655A1 (en) * 2006-04-21 2007-10-25 Haley Jeffrey T Lenticular shaped protective mouth sore discs
US20070248654A1 (en) * 2006-04-21 2007-10-25 Haley Jeffrey T Protective mouth sore discs made with corn starch
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20070264487A1 (en) * 2006-05-12 2007-11-15 Dean Georgiades Treated film strips
CN1850059B (en) * 2006-05-29 2010-05-12 王法平 Amlexanox oral membrane, and its preparing method
US20090208559A1 (en) * 2006-06-14 2009-08-20 Bruce Drew Device for delivering active ingredients to humans, animals and plants
US20070289596A1 (en) * 2006-06-14 2007-12-20 Campbell Shannon E Endotracheal cuff and technique for using the same
US20070298087A1 (en) * 2006-06-27 2007-12-27 Biegajski James E Two-phase mucoadhesive composition
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
JP2009542359A (en) 2006-06-29 2009-12-03 ボストン サイエンティフィック リミテッド Medical device with selective covering
KR101230804B1 (en) * 2006-07-21 2013-02-08 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 Transmucosal delivery devices with enhanced uptake
US8052743B2 (en) 2006-08-02 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
EP2068757B1 (en) 2006-09-14 2011-05-11 Boston Scientific Limited Medical devices with drug-eluting coating
JP2010503491A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Bioerodible endoprosthesis with biologically stable inorganic layers
EP2081616B1 (en) 2006-09-15 2017-11-01 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
CA2663220A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Medical devices and methods of making the same
EP2068782B1 (en) 2006-09-15 2011-07-27 Boston Scientific Limited Bioerodible endoprostheses
US8002821B2 (en) 2006-09-18 2011-08-23 Boston Scientific Scimed, Inc. Bioerodible metallic ENDOPROSTHESES
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057344A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US20080140106A1 (en) * 2006-12-12 2008-06-12 Kimberly-Clark Worldwide, Inc. Enhanced cuff sealing for endotracheal tubes
DE602007010669D1 (en) 2006-12-28 2010-12-30 Boston Scient Ltd HREN FOR THIS
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
CA2865389A1 (en) * 2007-03-29 2008-10-09 Progenics Pharmaceuticals, Inc. Crystal forms and uses thereof
EP2380564B1 (en) 2007-04-04 2014-10-22 Sigmoid Pharma Limited An oral pharmaceutical composition
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US20080260836A1 (en) * 2007-04-18 2008-10-23 Thomas James Boyd Films Comprising a Plurality of Polymers
CA2685118C (en) 2007-04-26 2016-11-01 Sigmoid Pharma Limited Manufacture of multiple minicapsules
JP2010526054A (en) * 2007-05-01 2010-07-29 シグモイド・ファーマ・リミテッド Combined pharmaceutical composition
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
EP2008651A1 (en) * 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
JP2010533563A (en) 2007-07-19 2010-10-28 ボストン サイエンティフィック リミテッド Endoprosthesis with adsorption inhibiting surface
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8221822B2 (en) 2007-07-31 2012-07-17 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
JP2010535541A (en) 2007-08-03 2010-11-25 ボストン サイエンティフィック リミテッド Coating for medical devices with large surface area
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
CN101152163B (en) * 2007-09-14 2010-05-26 李世荣 Anti-cicatrix externally used pad pasting containing hormone medicament and method for preparing the same
CN101152164B (en) * 2007-09-14 2011-04-06 李世荣 Anti-cicatrix externally used pad pasting containing anti-hypertrophy cell medicament and method for preparing the same
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
PE20091084A1 (en) * 2007-12-07 2009-07-23 Schering Plough Healthcare PHARMACEUTICAL FORMULATIONS OF PHENYLPHRINE AND COMPOSITIONS FOR TRANSMUCOSAL ABSORPTION
CN101229174B (en) * 2008-01-25 2010-12-15 广东一品红药业有限公司 Antianaphylaxis compound containing epinastine hydrochloride
US8920491B2 (en) 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US20090304776A1 (en) * 2008-06-06 2009-12-10 Totada Shantha Transmucosal delivery of therapeutic agents and methods of use thereof
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8449603B2 (en) 2008-06-18 2013-05-28 Boston Scientific Scimed, Inc. Endoprosthesis coating
CA2728912C (en) * 2008-06-23 2018-04-10 Biodelivery Sciences International, Inc. Multidirectional mucosal delivery devices and methods of use
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US8784879B2 (en) 2009-01-14 2014-07-22 Corium International, Inc. Transdermal administration of tamsulosin
WO2010101901A2 (en) 2009-03-02 2010-09-10 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
DK2471518T3 (en) 2009-05-18 2017-12-04 Sigmoid Pharma Ltd COMPOSITION INCLUDING OIL DROPS
WO2010135053A2 (en) * 2009-05-21 2010-11-25 Bionex Pharmaceuticals Llc Dual and single layer dosage forms
US8778278B2 (en) 2009-07-15 2014-07-15 General Electric Company Non bio-adhesive polymer coating composition, articles and devices thereof
US20110033515A1 (en) * 2009-08-04 2011-02-10 Rst Implanted Cell Technology Tissue contacting material
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US9878036B2 (en) 2009-08-12 2018-01-30 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
US20110037455A1 (en) * 2009-08-17 2011-02-17 Oren Navot System for measuring electrical power
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
TWI435733B (en) 2010-01-29 2014-05-01 Colgate Palmolive Co Oral care formulations for malodor control
PL2528536T3 (en) 2010-01-29 2016-04-29 Colgate Palmolive Co Dental strip for administration of oral treatment
US20110195042A1 (en) * 2010-02-10 2011-08-11 Thomas Edward Huetter Compositions, Methods and Kits Useful for Treating a Respiratory Symptom
SG10201504529WA (en) * 2010-03-09 2015-07-30 Alkermes Pharma Ireland Ltd Alcohol Resistant Enteric Pharmaceutical Compositions
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
US9572773B2 (en) * 2010-04-26 2017-02-21 Novartis A.G. Layered drug delivery device
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US8951598B2 (en) * 2010-05-07 2015-02-10 Empire Technology Development Llc Nanoscale collagen particles and membranes
SG185629A1 (en) * 2010-06-30 2012-12-28 Colgate Palmolive Co Flavor release from multilayer film during brushing
SG185630A1 (en) * 2010-06-30 2012-12-28 Colgate Palmolive Co Multilayer films for delivery of flavor
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
WO2012092594A2 (en) * 2010-12-30 2012-07-05 Harish Ziv M D Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
CN103533962B (en) 2011-03-14 2018-05-18 药品配送方案有限公司 A kind of ophthalmic composition
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
WO2013023775A1 (en) * 2011-08-12 2013-02-21 Labtec Gmbh Orodispersible films for the manufacturing of individualised medicine or for large scale production
EP2594257A1 (en) * 2011-11-17 2013-05-22 Labtec GmbH Orodispersible films for the manufacturing of individualised medicine or for large scale production
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
WO2013110340A1 (en) * 2012-01-27 2013-08-01 Beta Pharma S.A. Edible slow dissolving film for treating oral ulcerations
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
IN2014DN09031A (en) 2012-03-30 2015-05-22 Nuformix Ltd
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
CN105209084B (en) 2013-03-13 2018-07-03 艾利丹尼森公司 Improved bond properties
US20140271787A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Continuous single layer film structure including discrete domains
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
BR112016002205A2 (en) * 2013-07-31 2017-08-01 Bluepharma Ind Farmaceutica S A orodispersible films
WO2015020676A1 (en) * 2013-08-08 2015-02-12 Boston Scientific Scimed, Inc. Dissolvable or degradable adhesive polymer to prevent stent migration
EP3079656B8 (en) 2013-10-16 2020-02-26 Quest Products, LLC Treating mucosal lesions with hyaluronan delivered from an adhering troche
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
WO2015099640A1 (en) * 2013-12-23 2015-07-02 Colgate-Palmolive Company Film compositions for oral use
AU2013408896B2 (en) 2013-12-23 2017-03-02 Colgate-Palmolive Company Tooth whitening oral care product
EP2889030A1 (en) * 2013-12-30 2015-07-01 Uluru Inc. Controlling the erosion rates of mucoadhesive devices that deliver actives and other compounds and providing increased and variable therapeutic blood levels
US20160354509A1 (en) * 2014-02-10 2016-12-08 The Johns Hopkins University Devices for and methods of treatment of metabolic syndromes
ES2856347T3 (en) * 2014-02-12 2021-09-27 Sawai Seiyaku Kk Orally disintegrating film-coated tablet
CN104845549B (en) * 2014-02-18 2019-07-12 财团法人工业技术研究院 Wood adhesive, wood adhesion method using same and wood joint structure
EP2944565B1 (en) 2014-05-13 2017-09-27 Entrotech, Inc. Erosion protective sleeve
HUE045275T2 (en) 2014-07-31 2019-12-30 Johnson & Johnson Consumer Inc Article and method for maintaining menstrual fluid within the vagina
US11623008B2 (en) 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
ES2858517T3 (en) 2014-11-07 2021-09-30 Sublimity Therapeutics Ltd Compositions comprising cyclosporin
US20160144528A1 (en) 2014-11-25 2016-05-26 Biodelivery Sciences International, Inc. Patch devices, methods and apparatus for forming, and testing pharmaceutical agent delivery patch devices
CN108135835A (en) 2015-08-06 2018-06-08 约翰霍普金斯大学 For treating the composition of metabolic disorder and method
TWI564356B (en) 2015-09-18 2017-01-01 財團法人工業技術研究院 Wood adhesive
WO2017085262A1 (en) * 2015-11-19 2017-05-26 Dermtreat Aps A pharmaceutical film composition having improved residence time on the application site
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
JP7126260B2 (en) * 2016-01-27 2022-08-26 インスター テクノロジーズ アクチオヴァ スプルチュノスト Oral Mucosal Nanofiber Carriers for Therapeutic Treatment
GB2562439B (en) * 2016-01-28 2022-04-13 Kimberly Clark Co Adherent composition for RNA viruses and method of removing RNA viruses from a surface
EP3452023A1 (en) * 2016-05-05 2019-03-13 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
KR102627187B1 (en) 2016-05-26 2024-01-22 킴벌리-클라크 월드와이드, 인크. Anti-adhesion compositions and methods for inhibiting adhesion of microorganisms to surfaces
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CN107865868B (en) 2016-09-27 2020-04-10 上海微创医疗器械(集团)有限公司 New application of amlexanox
WO2018133910A1 (en) 2017-01-23 2018-07-26 Dermtreat Aps Method for preparing electrospun fibers with a high content of a bioadhesive substance
EP3570821B1 (en) 2017-01-23 2021-07-21 AFYX Therapeutics A/S Method for fabrication of a two-layered product based on electrospun fibres
RU2699808C2 (en) * 2017-12-05 2019-09-11 Общество с ограниченной ответственностью "Эндокринные технологии" Biodegradable system of transmucosal delivery of drotaverin
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
EP3807260A1 (en) 2018-06-15 2021-04-21 R. J. Reynolds Tobacco Company Purification of nicotine
US11291654B2 (en) * 2018-09-13 2022-04-05 Syneurx International (Taiwan) Corp. Formulations of cycloserine compounds and applications thereof
CN109953984A (en) * 2019-03-01 2019-07-02 哈尔滨医科大学 A kind of compound hydrochloric acid totokaine film and preparation method thereof
UY38610A (en) * 2019-03-14 2020-08-31 Univ Greifswald PHARMACEUTICAL DOSAGE FORM FOR APPLICATION TO MUCOUS MEMBRANES AND METHODS TO PRODUCE THE SAME
KR102234482B1 (en) * 2019-05-14 2021-03-31 조선대학교산학협력단 fluorine agent of dual film type using polymers with differential dissolution characteristics and manufacturing method thereof
RU2729659C1 (en) * 2019-05-29 2020-08-11 Общество с ограниченной ответственностью "Эндокринные технологии" Dosage form for releasing drotaverine in oral cavity
CN113134085A (en) * 2020-01-17 2021-07-20 四川大学华西第二医院 Medicine for treating white lesions of vulva
CN113181416B (en) * 2021-04-26 2022-04-05 苏州和塑美科技有限公司 Self-adhesive nanofiber antibacterial dressing easy to transfer and preparation method thereof
CN114848612A (en) * 2022-04-28 2022-08-05 青岛博益特生物材料股份有限公司 Sheet material film coating process and film coated sheet material produced by same

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513243A (en) * 1983-06-08 1985-04-23 Westinghouse Electric Corp. Core form transformer for selective cancellation of subsynchronous resonance
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US5437857A (en) * 1989-05-24 1995-08-01 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US6056930A (en) * 1989-05-24 2000-05-02 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US6419906B1 (en) * 2001-03-12 2002-07-16 Colgate Palmolive Company Strip for whitening tooth surfaces
US20030133884A1 (en) * 2000-03-17 2003-07-17 Sug-Youn Chang Patches for teeth whitening
US6649147B1 (en) * 1999-07-02 2003-11-18 The Procter & Gamble Company Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
US6682721B2 (en) * 2000-03-17 2004-01-27 Lg Household & Healthcare Ltd. Patches for teeth whitening
US6946142B2 (en) * 2001-06-23 2005-09-20 Lg Household & Healthcare Ltd. Multi-layer patches for teeth whitening
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3948254A (en) 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
GB1593097A (en) 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
JPS5758615A (en) 1980-09-26 1982-04-08 Nippon Soda Co Ltd Film agnent and its preparation
JPS5770816A (en) 1980-10-17 1982-05-01 Ono Pharmaceut Co Ltd Multilayered film preparation of prostagladin of prolonged action
JPS57110254A (en) 1980-12-29 1982-07-09 Teijin Ltd Coating agent of injured membrane part of oral cavity
CH653550A5 (en) * 1981-10-20 1986-01-15 Sandoz Ag PHARMACEUTICAL COMPOSITION FOR DELAYED RELEASE OF A MEDICINE IN THE ORAL AREA.
US4518721A (en) 1982-03-26 1985-05-21 Richardson-Vicks Inc. Hydrophilic denture adhesive
CA1208558A (en) 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
JPS59186913A (en) 1983-04-08 1984-10-23 Teikoku Seiyaku Kk Base to be applied to mucosa in oral cavity
JPH0830004B2 (en) 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド Bioadhesive composition and method of treatment therewith
US5855908A (en) 1984-05-01 1999-01-05 University Of Utah Research Foundation Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
US5783207A (en) 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
JPH0744940B2 (en) * 1986-12-24 1995-05-17 ライオン株式会社 Base material for oral application
DE3714074A1 (en) 1987-04-28 1988-11-10 Hoechst Ag BASIS FOR MUCUTINE AND PROSTHESISAL PASTE, METHOD FOR THEIR PRODUCTION AND PASTE BASED ON THIS BASE
US4915948A (en) 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
JP2635336B2 (en) * 1987-09-30 1997-07-30 帝國製薬株式会社 Sustained release oral preparation
US5081157A (en) 1988-05-02 1992-01-14 Zila Pharmaceuticals, Inc. Compositions and in situ methods for forming films on body tissue
US5081158A (en) 1988-05-02 1992-01-14 Zila Pharmaceuticals, Inc. Compositions and in situ methods for forming films on body tissue
US5047244A (en) 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
JP2656338B2 (en) 1989-01-31 1997-09-24 日東電工株式会社 Oral mucosa patch preparation
US5139023A (en) 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
DK0431719T3 (en) 1989-10-31 1995-02-27 Columbia Lab Inc Vaginal tissue wetting agent
ATE181824T1 (en) 1989-10-31 1999-07-15 Columbia Lab Inc AGENTS FOR MOISTURIZING TISSUES AND METHOD
US6017521A (en) 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
US5750136A (en) 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
US5750134A (en) 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
US5298258A (en) 1989-12-28 1994-03-29 Nitto Denko Corporation Acrylic oily gel bioadhesive material and acrylic oily gel preparation
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
EP0641192B1 (en) 1992-05-18 1997-07-23 Minnesota Mining And Manufacturing Company Transmucosal drug delivery device
US5543150A (en) 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
US5578315A (en) 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
US5458879A (en) 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
US5639469A (en) 1994-06-15 1997-06-17 Minnesota Mining And Manufacturing Company Transmucosal delivery system
US6103226A (en) * 1994-08-12 2000-08-15 Arch Development Corporation Genetically engineered cells that produce produce L. Dopa
WO1996009829A1 (en) 1994-09-27 1996-04-04 Virotex Corporation Improved topical carriers for mucosal applications
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5888534A (en) 1995-06-13 1999-03-30 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5624677A (en) 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
CA2184316A1 (en) 1995-09-12 1997-03-13 Wei-Chi Liao Buccal delivery system for therapeutic agents
IT1277663B1 (en) 1995-09-28 1997-11-11 Crinos Industria Farmaco STABLE AQUEOUS SUSPENSIONS OF MESALAZINE FOR TOPICAL USE
US5766620A (en) 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
US5849322A (en) 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
JP2791317B2 (en) * 1995-12-26 1998-08-27 株式会社三和化学研究所 Multilayer film preparation
US5889028A (en) 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
US5955098A (en) 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
AU2190697A (en) 1996-04-12 1997-11-07 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
US5869082A (en) 1996-04-12 1999-02-09 Flemington Pharmaceutical Corp. Buccal, non-polar spray for nitroglycerin
GB9610862D0 (en) * 1996-05-23 1996-07-31 Evans Brian K Pharmaceutical products
SE9602644D0 (en) 1996-07-04 1996-07-04 Astra Ab New use
US5861174A (en) 1996-07-12 1999-01-19 University Technology Corporation Temperature sensitive gel for sustained delivery of protein drugs
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
FR2762513B1 (en) * 1997-04-23 2003-08-22 Permatec Pharma Ag BIOADHESIVE TABLETS
US5900230A (en) 1997-08-18 1999-05-04 Squigle, Inc. Dental products to treat and prevent periodontal disease
US5981499A (en) 1998-02-20 1999-11-09 Atlantic Biomed Corporation Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
US6103266A (en) 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
JP2002512950A (en) 1998-04-29 2002-05-08 バイロテックス コーポレイション Drug carrier device suitable for delivering drug compounds to mucosal surfaces
GB9812426D0 (en) 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
ATE279914T1 (en) * 1998-11-27 2004-11-15 Kanji Takada ORALLY APPLICABLE MEDICINAL PRODUCT FOR ADMINISTRATION OF ACTIVE INGREDIENTS IN THE GITRIC INTESTINAL TRACT
US6284262B1 (en) 1999-01-26 2001-09-04 Virgil A. Place Compact dosage unit for buccal administration of a pharmacologically active agent
US6117446A (en) 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
ES2350306T3 (en) 1999-02-26 2011-01-20 Novartis Vaccines And Diagnostics, Inc. USE OF BIOADHESIVES AND ASSISTANTS FOR THE ADMINISTRATION OF ANTIGENS BY MUCOSA VIA.
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
JP2001163745A (en) * 1999-12-08 2001-06-19 Lion Corp Patch agent for oral use
IT1318649B1 (en) 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MUCOSITES AND STOMATITIS.

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513243A (en) * 1983-06-08 1985-04-23 Westinghouse Electric Corp. Core form transformer for selective cancellation of subsynchronous resonance
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US5437857A (en) * 1989-05-24 1995-08-01 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US6056930A (en) * 1989-05-24 2000-05-02 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US6649147B1 (en) * 1999-07-02 2003-11-18 The Procter & Gamble Company Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
US20030133884A1 (en) * 2000-03-17 2003-07-17 Sug-Youn Chang Patches for teeth whitening
US6682721B2 (en) * 2000-03-17 2004-01-27 Lg Household & Healthcare Ltd. Patches for teeth whitening
US6419906B1 (en) * 2001-03-12 2002-07-16 Colgate Palmolive Company Strip for whitening tooth surfaces
US6946142B2 (en) * 2001-06-23 2005-09-20 Lg Household & Healthcare Ltd. Multi-layer patches for teeth whitening
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070003495A1 (en) * 1997-06-06 2007-01-04 The Procter & Gamble Company Methods for whitening teeth
USRE42126E1 (en) 1999-07-02 2011-02-08 The Procter & Gamble Company Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
US20050100515A1 (en) * 2002-09-11 2005-05-12 The Procter & Gamble Company Tooth whitening products
US9554976B2 (en) 2002-09-11 2017-01-31 The Procter & Gamble Company Tooth whitening product
US10493016B2 (en) 2002-09-11 2019-12-03 The Procter & Gamble Company Tooth whitening product
US20040265245A1 (en) * 2003-05-27 2004-12-30 Allred Peter M. Substantially solid bleaching or treatment compositions in the form of inserts for dental trays, and kits comprising such inserts and trays
US7172423B2 (en) 2003-05-27 2007-02-06 Ultradent Products, Inc. Substantially solid bleaching or treatment compositions in the form of inserts for dental trays, and kits comprising such inserts and trays
US20050081760A1 (en) * 2003-07-01 2005-04-21 Leng Lu H. Table top
US20050072369A1 (en) * 2003-09-18 2005-04-07 Goossen Theodorus Jozef Submergible terrarium
US20070218015A1 (en) * 2003-11-03 2007-09-20 Craig Hardy Tooth-Whitening Composition
US20050196354A1 (en) * 2004-03-03 2005-09-08 Andre Soshinsky Film compositions
US20050196350A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Stabilized peroxide compositions
US20050196358A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Film products having controlled disintegration properties
US20050196348A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Stabilized peroxide compositions
US20070190125A1 (en) * 2004-03-03 2007-08-16 Constantine Georgiades Positioning feature for aiding use of film or strip product
US20080003248A1 (en) * 2004-03-03 2008-01-03 Constantine Georgiades Whitening products
US20070269519A1 (en) * 2004-03-03 2007-11-22 Constantine Georgiades Whitening products
WO2005102254A1 (en) * 2004-04-08 2005-11-03 The Procter & Gamble Company Tooth whitening products
WO2005110344A1 (en) 2004-05-10 2005-11-24 Colgate-Palmolive Company Multilayer tooth whitening strips
US20050276760A1 (en) * 2004-06-09 2005-12-15 Lornamead Brands, Inc. Tooth for whitening products and methods of making the same
US9149417B2 (en) 2004-06-09 2015-10-06 Lornamead Brands, Inc. Tooth whitening products and methods of making the same
US20080317797A1 (en) * 2004-06-09 2008-12-25 Lornamead Brands, Inc. Tooth whitening products and methods of making the same
US20080317703A1 (en) * 2004-08-02 2008-12-25 Gertrud Kawa Novel Composition for Xerostomia
WO2006013081A1 (en) * 2004-08-02 2006-02-09 Glaxo Group Limited Novel composition for xerostomia
US9044500B2 (en) 2004-08-02 2015-06-02 Glaxosmithkline Consumer Healthcare Gmbh & Co Kg Composition for xerostomia
US10350238B2 (en) 2004-08-02 2019-07-16 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Method of treating xerostomia
AU2005268926B2 (en) * 2004-08-02 2011-10-13 Glaxosmithkline Consumer Healthcare (Uk) Ip Limited Novel composition for xerostomia
US20080286317A1 (en) * 2004-10-13 2008-11-20 Lts Lohmann Therapie-Systeme Ag Self-Adhesive Film for Teeth
US10039711B2 (en) * 2004-10-13 2018-08-07 Lts Lohmann Therapie-Systeme Ag Self-adhesive film for teeth
US8137658B2 (en) 2005-06-28 2012-03-20 Isp Investments Inc. Tooth whitening compositions
US8741266B2 (en) 2005-12-21 2014-06-03 Colgate-Palmolive Company Cleaning and/or polishing compositions and methods of use thereof
US20070140985A1 (en) * 2005-12-21 2007-06-21 Boyd Thomas J Cleaning and/or Polishing Compositions and Methods of Use Thereof
WO2007076396A2 (en) 2005-12-21 2007-07-05 Colgate-Palmolive Company Cleaning and/or polishing compositions and methods for use thereof
AU2007272773B2 (en) * 2006-07-14 2011-03-31 Colgate-Palmolive Company Methods of making compositions comprising films
WO2008008617A2 (en) 2006-07-14 2008-01-17 Colgate-Palmolive Company Methods of making compositions comprising films
US9682256B2 (en) 2006-07-14 2017-06-20 Colgate-Palmolive Company Methods of making compositions comprising films
US20080014224A1 (en) * 2006-07-14 2008-01-17 Boyd Thomas J Methods of Making Compositions Comprising Films
WO2008157033A1 (en) * 2007-06-20 2008-12-24 Mcneil-Ppc, Inc Products for whitening teeth
EP2113238A1 (en) * 2007-06-21 2009-11-04 McNeil-PPC, Inc. Products for whitening teeth
US9138384B2 (en) 2009-04-02 2015-09-22 Colgate-Palmolive Company Color changing consumer products
US8647648B2 (en) 2009-04-02 2014-02-11 Colgate-Palmolive Company Color changing consumer products
RU2482836C1 (en) * 2009-04-02 2013-05-27 Колгейт-Палмолив Компани Consumer products changing colour
US9271906B2 (en) 2010-11-08 2016-03-01 Colgate-Palmolive Company Oral compositions containing microaggregates
WO2012064319A1 (en) 2010-11-08 2012-05-18 Colgate-Palmolive Company Oral compositions containing microaggregates
WO2012082098A1 (en) 2010-12-13 2012-06-21 Colgate-Palmolive Company Oral compositions and method for producing thereof
WO2012082103A1 (en) 2010-12-13 2012-06-21 Colgate-Palmolive Company Oral compositions and method for producing thereof
WO2012082101A1 (en) 2010-12-13 2012-06-21 Colgate-Palmolive Company Oral compositions and method for producing thereof
US9259377B2 (en) 2010-12-13 2016-02-16 Colgate-Palmolive Company Oral compositions and method for producing thereof
US9675540B2 (en) 2010-12-13 2017-06-13 Colgate-Palmolive Company Oral compositions and method for producing thereof
US9205058B2 (en) 2011-06-27 2015-12-08 Industry-Academic Cooperation Foundation, Chosun University Tape-type fluorine preparation using biodegradable polymer and method of preparing the same
KR101328162B1 (en) 2011-06-27 2013-11-13 조선대학교산학협력단 fluorine agent of tape type using biodegradable polymers and manufacturing method thereof
WO2013002505A1 (en) * 2011-06-27 2013-01-03 조선대학교 산학협력단 Tape-type fluorine preparation using a biodegradable polymer material, and method for producing same
WO2013087623A2 (en) 2011-12-12 2013-06-20 Glaxo Group Limited Novel composition

Also Published As

Publication number Publication date
PL373327A1 (en) 2005-08-22
WO2003015748A2 (en) 2003-02-27
IL160410A (en) 2009-08-03
RU2004107575A (en) 2005-04-20
CN1738599A (en) 2006-02-22
MXPA04001491A (en) 2004-05-17
NZ531766A (en) 2005-12-23
AU2002326664B2 (en) 2008-03-06
US20030044446A1 (en) 2003-03-06
CA2459692A1 (en) 2003-02-27
WO2003015748A3 (en) 2003-12-04
IL160410A0 (en) 2004-09-27
IS7155A (en) 2004-02-16
HUP0401281A2 (en) 2004-11-29
ZA200402067B (en) 2005-05-28
EP1418889A2 (en) 2004-05-19
RU2343903C2 (en) 2009-01-20
IL160419A0 (en) 2004-09-27
US6585997B2 (en) 2003-07-01
JP2010159268A (en) 2010-07-22
JP2005504763A (en) 2005-02-17
HUP0401281A3 (en) 2008-04-28
CN101849924A (en) 2010-10-06
KR20040039290A (en) 2004-05-10

Similar Documents

Publication Publication Date Title
US20040062724A1 (en) Erodible film for treating the surfaces of teeth
US20060073174A1 (en) Adherent and erodible film to treat a moist surface of a body tissue
JP5599548B2 (en) Hydrogel composition having a corrosive backing member
EP1401385B1 (en) Multiple-layered patches for teeth whitening
US9149417B2 (en) Tooth whitening products and methods of making the same
US20060018845A1 (en) Tooth whitening
JP2007505135A5 (en)
US20090238778A1 (en) Tooth whitening compositions, delivery systems and methods
EP1736135A1 (en) Oral care compositions, devices, and methods of using the same
JP2006528984A (en) Hydrogel composition exhibiting phase separation
JPH09504810A (en) Water-soluble pressure sensitive mucoadhesive
WO2007062414A1 (en) Hydrogel sheets and shapes for oral care
AU2009202487A1 (en) Teeth bleaching compositions and devices
KR20210024080A (en) Oral composition and mucoadhesive thin film formed therefrom
US20040219190A1 (en) Multi-layer transenamel bleaching system
KR20210135976A (en) Oral formulation comprising hardening composition having ointment form
KR100550065B1 (en) Patch attached hydrogel matrix for dental-whitening
KR100796385B1 (en) Thin-Film type Tooth Whitener
JP2000063268A (en) Oral mucosa adhesion-type controlled release troche and periodontal disease therapeutic agent
JP2000178185A (en) Oral mucous membrane-adhering type sustained release tablet
EP1715835B1 (en) Tooth-whitening composition
KR102514119B1 (en) Dental wrap, dental kit comprising the same, method of using the same, and method for whitening teeth using the same
JPH0696518B2 (en) Oral formulation
CA3106007A1 (en) Dental wrap, dental kit comprising the same, method of using the same, and method for whitening teeth using the same

Legal Events

Date Code Title Description
AS Assignment

Owner name: ACCESS PHARMACEUTICALS, INC., TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MORO, DANIEL G.;CALLAHAN, ERNEST HOWARD JR.;NOWOTNIK, DAVID P.;REEL/FRAME:014526/0487

Effective date: 20030924

AS Assignment

Owner name: ULURU INC., TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACCESS PHARMACEUTICALS, INC.;REEL/FRAME:017706/0576

Effective date: 20060530

AS Assignment

Owner name: ULURU INC., TEXAS

Free format text: CONVEYANCE OF ALL RIGHT, TITLE AND INTEREST TO THE CORRESPONDING FOREIGN PATENTS AND PENDING APPLICATIONS TO THE RIGHTS PREVIOUSLY RECORDED ON REEL;ASSIGNOR:ACCESS PHARMACEUTICALS, INC.;REEL/FRAME:018015/0043

Effective date: 20060725

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION